EGFR and glioblastoma: To characterize whether EGFR-overexpressed or mutated carcinoma cells are sensitive to cinobufagin, we screened more cancer cell lines, including glioblastoma, lung cancer, colorectal cancer (CRC), and liver cancer cell lines, with different status of EGFR.